CrestPoint Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
2017
Q3
$533K Sell
2017
Q2
$487K Buy
2016
Q4
Sell
2016
Q3
$294K Sell
2016
Q2
$292K Hold
2016
Q1
$348K Buy
2015
Q4
$439K Hold
2015
Q3
$360K Buy
2015
Q1
Sell
2014
Q4
$222K Sell
2014
Q3
$216K Sell
2014
Q2
$516K Buy
2014
Q1
$441K Hold
2013
Q4
$385K Buy